Evaluation of Efficacy of Cryotherapy for Skin Anesthesia During Arterial Puncture (SNOW)

July 22, 2022 updated by: Jacq Gwenaelle, Versailles Hospital

Evaluation of Efficacy of Cryotherapy for Skin Anesthesia During Arterial Puncture for Blood Gas in Critically Ill Patients. SNOW Study

the purpose of this study is to evaluate the cryotherapy effect by vapocoolant spray to reducing pain during puncture for artérial blood gas

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Blood gas analysis by arterial puncture is the Gold Standard in the assessment of a patient's acidbase status and oxygenation. This procedure, which can be repeated depending on the clinical condition of patient, is however associated with a potentially painful experience for patients.

The known anesthetic properties of cold can be an interesting alternative to evaluate in the reduction of pain induced during arterial puncture for gas analysis in critically il patients.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Belfort, France, 90015
        • Hôpital Nord Franche-Comté
      • Le Chesnay, France, 78150
        • CH Versailles
      • Paris, France, 75015
        • Hopital Europeen Georges Pompidou
      • Paris, France, 75010
        • CHU Saint Louis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 120 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All adult patients (age≥18 years) hospitalized in Intensive Care Unit
  • Patient requiering arteriale puncture for ABG
  • A négative score of CAM ICU scale
  • Patient with a score to visual analog scale < or equal 30mm
  • Securité sociale affiliated
  • consentement

Exclusion Criteria:

  • patient undergoing mechanical ventilation
  • patient with arterial catheter
  • patient with arterio veinius fistul
  • patient receiving topical anesthesic at least 2 h before the puncture
  • patient with cutaneous lesion (zone of puncture)
  • Raynaud Syndrom
  • cold sensibility
  • Allen test negative
  • pregnant
  • legal guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cryotherapy group
cryotherapy by vapocoolant spray is applied on skin for 4 to 10 seconds ( or up to skin whitening) to 15 centimeters distance with sweeping action before ABG
patients recieving cryotherapy for skin anesthesia for artérial blood gas
Placebo Comparator: control group
water spray is applied on skin for 4 to 10 seconds to centimeters distance with sweeping action before ABG
patients recieving cryotherapy for skin anesthesia for artérial blood gas

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain during arterial puncture
Time Frame: immediately after puncture
Pain will be assessed with the visual analog scale (numeric value go 0 to 100 millimeters and representing intensity of pain from "no pain" to "worst pain imaginable"(1)
immediately after puncture

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease to performing Arterial Blood Gas (ABG) sampling
Time Frame: immediately after puncture
Ease to performing ABG sampling will be evaluated by i)the number of punctures necessary to obtain a sample of at least 1ml of arterial blood, ii) the delay between the first arterial puncture, and obtaining a sample.
immediately after puncture

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2020

Primary Completion (Actual)

November 30, 2021

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

May 27, 2019

First Submitted That Met QC Criteria

June 1, 2019

First Posted (Actual)

June 4, 2019

Study Record Updates

Last Update Posted (Actual)

July 25, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • P17/04_SNOW
  • 2018-A00702-53 (Other Identifier: Registry ID: ID RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cryotherapy Effect

Clinical Trials on Cryotherapy

3
Subscribe